Ritika Anil Kumar
About Ritika Anil Kumar
Data last updated:
Ritika Anil Kumar is a Director at Nark Pharmaceuticals Private Limited (since 2018). The company operates in Trading. Nark Pharmaceuticals Private Limited reported revenue of ₹2.64 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nark Pharmaceuticals Private Limited U51397KL2010PTC027169 | Director | 27 Sep 2018 | 2010 | ₹2.64 Cr (FY 2025) | Active |
Board colleagues of Ritika Anil Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Navakumar Narayanan | 01430410 | Nark Pharmaceuticals Private Limited | Managing Director |
| Sudhakara Reddy Dodla | 01387896 | Nark Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ritika Anil Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ritika Anil Kumar
Ritika Anil Kumar currently holds 1 directorship: Nark Pharmaceuticals Private Limited (Director, since 27 Sep 2018, revenue ₹2.64 Cr (FY 2025)).
Ritika Anil Kumar was first appointed on 27 Sep 2018 as Director at Nark Pharmaceuticals Private Limited.
The current boards of Ritika Anil Kumar's companies include Navakumar Narayanan (Nark Pharmaceuticals Private Limited), Sudhakara Reddy Dodla (Nark Pharmaceuticals Private Limited).